News Archives » access to medicines
Jubilee USA Network Hosts 2018 Council Meeting November 13th, 2018
On November 7 and 8 Jubilee USA held its Annual National Council Meeting to inform constituents about the crisis in Puerto Rico, responsible lending and borrowing practices in the developing world, especially in Somalia, and Africa’s new debt crisis.
Jubilee USA is a coalition of diverse organizations and international partners including faith communities who advocate for debt cancellation for the world’s most impoverished countries. They also promote fiscal responsible economic policies. Missionary Oblates of Mary Immaculate JPIC has long been a participating member of Jubilee USA. Staff recently attended the 2018 council meeting held at the Methodist building on Capitol Hill in Washington DC.
The annual meeting events included a congressional briefing on November 7 focused on the theme; Lifting Vulnerable Communities: Ensuring Access to Medicines in Trade and Agreements and US Policy. Presenters at the Jubilee USA council meeting were representatives from American Friends Service Committee (AFSC), Puerto Rico Coalition on the Debt and American Federation of Labor and Congress of Industrial Organizations (AFL-CIO). Panelists reminded attendees of the urgency of the Puerto Rico debt crisis and their recovery efforts, and the growing debt crisis in Somalia and other nations in Africa.
Engage with Jubilee USA by participating in Jubilee Weekend 2018. Join other Religious groups and partners in a weekend of reflection, prayers and actions to end extreme poverty and transform our global economic system.
- Sign up here and find resource for actions and prayers for Jubilee Weekend November 16 – 18, 2018: https://www.jubileeusa.org/jubilee_weekend
Important Advances in Pediatric AIDS Drug Development December 3rd, 2014
World AIDS Day saw two important announcements regarding development of much-needed pediatric AIDS drugs. This is an issue on which the Oblates and other faith-based investors in the Interfaith Center on Corporate Responsibility (ICCR) have pressed pharmaceutical companies on for years. Since most pediatric AIDS patients are in poor, developing countries, the usual market incentive for drug development does not exist. And, the development of pediatric AIDS drugs, particularly for infants, is challenging. ICCR members have actively encouraged the major pharmaceutical companies to participate in the Medicines Patent Pool, a mechanism established under the auspices of the UN to ‘pool’ patents for drugs to make existing formulations more readily available for generic production and for innovative fixed dose combinations to be developed.
On Monday, World AIDS Day, Abbvie announced a licensing agreement for lopinavir (LPV) and ritonavir (r), top World Health Organization-recommended medicines for children. The license will enable other companies and organizations to re-formulate and manufacture specially designed LPV/r and r pediatric treatments for distribution in low- and middle-income countries where 99% of children with HIV in the developing world live. [Abbvie is a spinoff of Abbott Laboratories that contains the research-based pharmaceutical business.]
On the same day, the HIV Medicines Research Industry Forum announced that the forum is joining PEPFAR, the Global Fund, and the Pediatric HIV Treatment Initiative (PHTI) in the newly established “Global Pediatric Antiretroviral (ARV) Commitment-to-Action” to accelerate innovation and save children’s lives. The initiative is designed to accelerate the development of new, high-priority pediatric ARV co-formulations for first- and second-line treatment by 2017.
Click here to read more »
Faith-Based Investors Call on Pharmaceutical Companies to Join the Medicines Patent Pool November 30th, 2011
In honor of World AIDS Day and the United Nation’s theme, “Getting to Zero”, members of the Interfaith Center on Corporate Responsibility (ICCR) reiterate their endorsement of the Medicines Patent Pool (MPP) created by UNITAID, and call upon pharmaceutical companies to share their licenses for life-savings AIDS medicines.
“The ‘Getting to Zero’ theme has three main goals,” said Christina Herman of the Missionary Oblates of Mary Immaculate: “Zero new infections, zero discrimination and zero AIDS-related deaths: The MPP is an effective and powerful strategy against all three. As investors in pharmaceutical companies who view access to medicines as a fundamental human right, we strongly encourage participation.”